Fiche du document
14 mars 2022
- doi: 10.1016/j.ccell.2022.02.004
- issn: 1535-6108
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ccell.2022.02.004
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35176235
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1878-3686
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_51451730613C4
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Therapeutic immunology EndotheliocytesCiter ce document
W. Held et al., « Stem-cell-like T cells have a specific entry gate to the tumor. », Serveur académique Lausannois, ID : 10.1016/j.ccell.2022.02.004
Métriques
Partage / Export
Résumé
Tumor-infiltrated T cells with stem-cell-like properties are important for determining the immunotherapy response. In this issue of Cancer Cell, Asrir and colleagues show that their entry requires specialized tumor-associated endothelial cells that resemble immature and inflamed lymph node vessels and that immunotherapy enhances the recruitment capacity of these endothelial cells.